Oxford Immunotec Global PLC Announces Pricing of Underwritten Public Offering of Ordinary Shares
August 15, 2017 09:00 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug. 15, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec Global PLC Announces Agreement to Sell 2,500,000 Ordinary Shares
August 14, 2017 16:20 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec Reports Second Quarter 2017 Financial Results
August 01, 2017 07:00 ET
|
Oxford Immunotec
Second quarter revenue of $26.1 million, an increase of 36% compared to prior year periodContinued growth from both the Tuberculosis and Tick-borne disease franchisesSuccessful negotiation of a...
Oxford Immunotec Appoints Richard Wenstrup, MD, as Chief Medical Officer
July 24, 2017 09:00 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec Schedules Second Quarter 2017 Earnings Release and Conference Call for August 1, 2017
July 18, 2017 09:00 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 18, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing...
Oxford Immunotec Announces National Reimbursement for the T-SPOT®.TB Test in France
June 22, 2017 16:43 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., June 22, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation
June 15, 2017 16:05 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., June 15, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec Names Karen Koski Head of Strategy and Investor Relations
June 05, 2017 07:30 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., June 05, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and...
Oxford Immunotec Reports First Quarter 2017 Financial Results
May 02, 2017 07:00 ET
|
Oxford Immunotec
First quarter revenue of $21.5 million, an increase of 26% compared to prior year periodFirst quarter Tuberculosis revenue of $18.5 million, an increase of 8% compared to prior year periodFirst...
Oxford Immunotec Schedules First Quarter 2017 Earnings Release and Conference Call for May 2, 2017
April 19, 2017 16:05 ET
|
Oxford Immunotec
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 19, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on...